Search This Blog

Wednesday, August 7, 2019

Arena Pharmaceuticals EPS misses by $0.17, misses on revenue

Arena Pharmaceuticals (NASDAQ:ARNA): Q2 GAAP EPS of -$1.24 misses by $0.17.
Revenue of $1.02M (-74.4% Y/Y) misses by $1.89M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)